Biotech Values

[oc631]

So, sounds like they think the nuke has issues combining with pegIFN. Is that your take?

That's what GILD would like investors to believe at this point.

How do they know the SAEs aren't attributable to the nuke alone or to their PI, either alone, or in combo with another agent?

They don't. I personally believe there's more to the story and the FDA is being accommodating by allowing them to continue oral development. The street won't be so kind come Monday IMO.